Concepedia

Michael Lang

ML

Statistics

Publications

10

Citations

394

H-Index

10

Active since

1985

Affiliations

Center for Innovation(Current)

Michael Lang is an author at Center for Innovation specializing in multiple sclerosis pharmacotherapy, neurology, and pharmacotherapy.

Publications per year

1985–2018

10

Publications

10

Lung cancer risk in nonsmokers and GSTM1 and GSTT1 genetic polymorphism.

Núria Malats, A M Camus-Radon, Fredrik Nyberg et al. · PubMed · 2000 · 93 citations

, , +17

Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis—Report of Two Cases

Daniela Rau, Michael Lang, Andreas Harth et al. · International Journal of Molecular Sciences · 2015 · 80 citations · Full text

, , +17

Patient-rated suitability of a novel electronic device for self-injection of subcutaneous interferon beta-1a in relapsing multiple sclerosis: an international, single-arm, multicentre, Phase IIIb study

Virginia Devonshire, Txomin Arbizu, Björn Borre et al. · BMC Neurology · 2010 · 47 citations · Full text

, , +7

Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort

Stefan Braune, Michael Lang, Arnfin Bergmann · Journal of Neurology · 2013 · 44 citations · Full text

, , +15

Efficacy of fingolimod is superior to injectable disease modifying therapies in second-line therapy of relapsing remitting multiple sclerosis

Stefan Braune, Michael Lang, Arnfin Bergmann · Journal of Neurology · 2015 · 31 citations · Full text

, , +15

1–5 of 10